These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 21291764)

  • 1. Lipoprotein metabolism in an apoB-80 familial hypobetalipoproteinemia heterozygote.
    Hooper AJ; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PHR; van Bockxmeer FM; Burnett JR
    Clin Biochem; 2016 Jun; 49(9):720-722. PubMed ID: 26916057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
    Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR
    Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis.
    Ikewaki K; Schaefer JR; Frischmann ME; Okubo K; Hosoya T; Mochizuki S; Dieplinger B; Trenkwalder E; Schweer H; Kronenberg F; Koenig P; Dieplinger H
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2615-22. PubMed ID: 16195474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ezetimibe on the in vivo kinetics of apoB-48 and apoB-100 in men with primary hypercholesterolemia.
    Tremblay AJ; Lamarche B; Cohn JS; Hogue JC; Couture P
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1101-6. PubMed ID: 16528005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis.
    Lam MC; Singham J; Hegele RA; Riazy M; Hiob MA; Francis G; Steinbrecher UP
    Case Rep Gastroenterol; 2012 May; 6(2):429-37. PubMed ID: 22855658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.
    Fisher E; Lake E; McLeod RS
    J Biomed Res; 2014 May; 28(3):178-93. PubMed ID: 25013401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Variant in
    Surakka I; Hornsby WE; Farhat L; Rubenfire M; Fritsche LG; Hveem K; Chen YE; Brook RD; Willer CJ; Weinberg RL
    JACC Case Rep; 2020 May; 2(5):775-779. PubMed ID: 34317346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report of familial hypobetalipoproteinemia: a novel APOB mutation and literature review.
    Park SY; Kim HS; Chu MA; Jang HJ; Kang S
    Ann Pediatr Endocrinol Metab; 2023 Dec; 28(Suppl 1):S9-S11. PubMed ID: 36758975
    [No Abstract]   [Full Text] [Related]  

  • 11. A Rare Mutation in The
    Musialik J; Boguszewska-Chachulska A; Pojda-Wilczek D; Gorzkowska A; Szymańczak R; Kania M; Kujawa-Szewieczek A; Wojcieszyn M; Hartleb M; Więcek A
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Variant in
    Ayoub C; Azar Y; Abou-Khalil Y; Ghaleb Y; Elbitar S; Halaby G; Jambart S; Gannagé-Yared MH; Yaghi C; Saade Riachy C; El Khoury R; Rabès JP; Varret M; Boileau C; El Khoury P; Abifadel M
    Metabolites; 2021 Aug; 11(9):. PubMed ID: 34564380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypobetalipoproteinemia due to a novel early stop mutation.
    Durrington PN; Charlton-Menys V; Packard CJ; Caslake MJ; Wang J; Bhatnagar D; Scott J; Hegele RA
    J Clin Lipidol; 2008 Oct; 2(5):384-90. PubMed ID: 21291764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
    Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
    Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia.
    Whitfield AJ; Marais AD; Robertson K; Barrett PH; van Bockxmeer FM; Burnett JR
    Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872264
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.